Related references
Note: Only part of the references are listed.Biology and Treatment of Meningiomas A Reappraisal
J. Ricardo McFaline-Figueroa et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2022)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry
Desmond A. Brown et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
Metin Karahoca et al.
CLINICAL EPIGENETICS (2013)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
Impaired survival and long-term neurological problems in benign meningioma
Hanna van Alkemade et al.
NEURO-ONCOLOGY (2012)
Decellularized Porcine Brain Matrix for Cell Culture and Tissue Engineering Scaffolds
Jessica A. DeQuach et al.
TISSUE ENGINEERING PART A (2011)
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
Giovanni L. Gravina et al.
MOLECULAR CANCER (2010)
LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION
Manish K. Aghi et al.
NEUROSURGERY (2009)
Evolution of decitabine development - Accomplishments, ongoing investigations, and future strategies
Elias Jabbour et al.
CANCER (2008)
Atypical and malignant meningioma: Outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network
David Pasquier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria
Blake E. Pearson et al.
NEUROSURGICAL FOCUS (2008)
Share Paper
